Sept 29 (Reuters) - LifeSci Acquisition Corp LSAC.O :
* LIFESCI ACQUISITION CORP - ANNOUNCES MERGER AGREEMENT WITH
VINCERA PHARMA
* LIFESCI ACQUISITION CORP - COMBINED COMPANY IS EXPECTED TO
HAVE
ABOUT $60 MILLION IN CASH AT CLOSING
* LIFESCI ACQUISITION CORP - COMBINED CO'S COMMON STOCK WILL
REMAIN LISTED ON NASDAQ UNDER NEW TICKER SYMBOL "VINC"
* LIFESCI ACQUISITION CORP - POST-CLOSING, STOCKHOLDERS WILL
INCLUDE ACUTA CAPITAL AND OTHERS
* LIFESCI ACQUISITION CORP - EXPECTED THAT LSAC WILL BE
RENAMED
VINCERA PHARMA
* LIFESCI ACQUISITION CORP - VINCERA WILL BE LED BY CEO
AHMED
HAMDY
* LIFESCI ACQUISITION CORP - COMPLETION OF MERGER IS SUBJECT
TO
EXECUTION OF LICENSE AGREEMENT WITH BAYER
Source text for Eikon: ID:nGNX2q9Z6d
Further company coverage: LSAC.O
((Reuters.Briefs@thomsonreuters.com;))